FXN and Friedreich ataxia: Overall, neuropathology demonstrates the progressive, degenerative nature of cerebellar pathology in FRDA as well as the severe loss of large projection neurons in the DN, confirming that they constitute a major cellular target for frataxin-restoring therapies.